% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • waithamcross waithamcross Jan 14, 2014 1:57 PM Flag

    all bad news priced into SRPT shares.... just imagine if the FDA has a backbone and saves these kids

    with an early approval .. SRPT will triple overnight

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This will be back to 28 to 32 by the end of month with just decent JPM presentation and no overall mkt correction. Tax loss money will come surging back in during next two weeks. JMHO

    • JMO

      the trading in this stock off the GSK news yesterday tells me, loudly, that the stock is riddled with net shorts, and that some very meaningful portion of the short interest is in fact, not hedged (just like it was NOT on October 12, 2012)

      the consenus on Srpt forward prospects appears to be luke warm, at best

      if the FDA shifts gears with Srpt, I suspect the stock would at least triple

      maybe more, initially, due to the unhedged shorts in this stock

      • 1 Reply to simp08801
      • unfortunately, the stock has been riddled by unhedged , large shorts for as long as I can remember. So far, they are 1 out of 2, in that they had their shorts handed to them 10/12, but got more than lucky when the FDA erroneously determined that GSK's data implied there wasn't a direct correlation between dystrophin production and clinical benefi.............. How will things play out this time around? I think these aggressive shorts are probably the original group who lost HUGE on 10/12, and they've been angling to make back what they lost ever since, at any cost.

        Cmon FDA..........................make my day. Admit you were premature in your conclusions, and do the right thing, not the least of which would be to help shed SRPT of these vultures.

13.54+0.30(+2.27%)Apr 20 4:00 PMEDT